Xiaoyi Bao

1.3k total citations
26 papers, 911 citations indexed

About

Xiaoyi Bao is a scholar working on Molecular Biology, Complementary and alternative medicine and Surgery. According to data from OpenAlex, Xiaoyi Bao has authored 26 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Complementary and alternative medicine and 5 papers in Surgery. Recurrent topics in Xiaoyi Bao's work include Traditional Chinese Medicine Analysis (8 papers), Inflammasome and immune disorders (5 papers) and Cardiac Ischemia and Reperfusion (3 papers). Xiaoyi Bao is often cited by papers focused on Traditional Chinese Medicine Analysis (8 papers), Inflammasome and immune disorders (5 papers) and Cardiac Ischemia and Reperfusion (3 papers). Xiaoyi Bao collaborates with scholars based in China and United Kingdom. Xiaoyi Bao's co-authors include Yan Wang, Guo‐qing Zheng, Qun Zheng, Xing Luo, Jiazhen Zhu, Xiuzhu Weng, Xiaoxuan Bai, Qiang Tong, Haibo Jia and Bo Yu and has published in prestigious journals such as The FASEB Journal, Free Radical Biology and Medicine and Biochemical Pharmacology.

In The Last Decade

Xiaoyi Bao

25 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyi Bao China 19 450 197 114 111 108 26 911
Xiaohu Chen China 14 429 1.0× 135 0.7× 136 1.2× 84 0.8× 114 1.1× 48 808
Xiangning Cui China 18 537 1.2× 116 0.6× 145 1.3× 76 0.7× 158 1.5× 34 1.2k
Mingjing Zhao China 16 462 1.0× 170 0.9× 150 1.3× 74 0.7× 272 2.5× 69 962
Dazhuo Shi China 19 431 1.0× 274 1.4× 117 1.0× 82 0.7× 266 2.5× 81 1.0k
Yunman Wang China 20 421 0.9× 114 0.6× 74 0.6× 72 0.6× 67 0.6× 36 1.1k
Huifeng Hao China 14 354 0.8× 77 0.4× 141 1.2× 132 1.2× 95 0.9× 35 863
Galina Chipitsyna United States 20 516 1.1× 245 1.2× 149 1.3× 83 0.7× 124 1.1× 39 1.3k
Li Yan China 14 314 0.7× 185 0.9× 77 0.7× 86 0.8× 71 0.7× 31 641
Juntian Liu China 14 313 0.7× 133 0.7× 97 0.9× 87 0.8× 66 0.6× 31 786
Qiao Yang China 19 484 1.1× 104 0.5× 131 1.1× 63 0.6× 220 2.0× 48 1.1k

Countries citing papers authored by Xiaoyi Bao

Since Specialization
Citations

This map shows the geographic impact of Xiaoyi Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyi Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyi Bao more than expected).

Fields of papers citing papers by Xiaoyi Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyi Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyi Bao. The network helps show where Xiaoyi Bao may publish in the future.

Co-authorship network of co-authors of Xiaoyi Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyi Bao. A scholar is included among the top collaborators of Xiaoyi Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyi Bao. Xiaoyi Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bai, Xiaoxuan, Ying Wang, Xing Luo, et al.. (2024). Cigarette tar accelerates atherosclerosis progression via RIPK3-dependent necroptosis mediated by endoplasmic reticulum stress in vascular smooth muscle cells. Cell Communication and Signaling. 22(1). 41–41. 9 indexed citations
3.
Bao, Xiaoyi, Xing Luo, Xiaoxuan Bai, et al.. (2023). Cigarette tar mediates macrophage ferroptosis in atherosclerosis through the hepcidin/FPN/SLC7A11 signaling pathway. Free Radical Biology and Medicine. 201. 76–88. 52 indexed citations
4.
Weng, Xiuzhu, Xing Luo, Xinyu Dai, et al.. (2023). Apigenin inhibits macrophage pyroptosis through regulation of oxidative stress and the NF‐κB pathway and ameliorates atherosclerosis. Phytotherapy Research. 37(11). 5300–5314. 24 indexed citations
5.
Luo, Xing, Yuwu Chen, Xiaoyi Bao, et al.. (2023). Combining metabolomics and OCT to reveal plasma metabolic profiling and biomarkers of plaque erosion and plaque rupture in STEMI patients. International Journal of Cardiology. 390. 131223–131223. 1 indexed citations
6.
Bao, Xiaoyi, et al.. (2023). Association between fasting stress hyperglycemia ratio and contrast-induced acute kidney injury in coronary angiography patients: a cross-sectional study. Frontiers in Endocrinology. 14. 1300373–1300373. 12 indexed citations
7.
Lv, Ying, Shan Zhang, Xiuzhu Weng, et al.. (2023). Estrogen deficiency accelerates postmenopausal atherosclerosis by inducing endothelial cell ferroptosis through inhibiting NRF2 / GPX4 pathway. The FASEB Journal. 37(6). e22992–e22992. 43 indexed citations
8.
Zhang, Shan, Ying Lv, Xing Luo, et al.. (2023). Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder. Molecular Medicine. 29(1). 73–73. 32 indexed citations
9.
Chen, Yuwu, et al.. (2022). Oxidative Stress-Mediated Programmed Cell Death: a Potential Therapy Target for Atherosclerosis. Cardiovascular Drugs and Therapy. 38(4). 819–832. 14 indexed citations
10.
Luo, Xing, Xiuzhu Weng, Xiaoyi Bao, et al.. (2022). A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis. Redox Biology. 57. 102511–102511. 95 indexed citations
11.
Bao, Xiaoyi, et al.. (2021). Buyang Huanwu Decoction Enhances Revascularization via Akt/GSK3β/NRF2 Pathway in Diabetic Hindlimb Ischemia. Oxidative Medicine and Cellular Longevity. 2021(1). 1470829–1470829. 21 indexed citations
12.
Luo, Xing, Ying Lv, Xiaoxuan Bai, et al.. (2021). Plaque Erosion: A Distinctive Pathological Mechanism of Acute Coronary Syndrome. Frontiers in Cardiovascular Medicine. 8. 711453–711453. 35 indexed citations
13.
Zheng, Qun, Jiazhen Zhu, Xiaoyi Bao, et al.. (2018). A Preclinical Systematic Review and Meta-Analysis of Astragaloside IV for Myocardial Ischemia/Reperfusion Injury. Frontiers in Physiology. 9. 795–795. 31 indexed citations
14.
Bao, Xiaoyi, et al.. (2018). Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool. Frontiers in Pharmacology. 9. 1445–1445. 21 indexed citations
15.
Zhang, Xiaoguang, Chang Shan, Jiazhen Zhu, et al.. (2018). Additive Neuroprotective Effect of Borneol with Mesenchymal Stem Cells on Ischemic Stroke in Mice. Frontiers in Physiology. 8. 1133–1133. 22 indexed citations
16.
Zheng, Qun, Yue-Yue Huang, Qiang Tong, et al.. (2018). Ligustrazine Exerts Cardioprotection in Animal Models of Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms. Frontiers in Pharmacology. 9. 729–729. 30 indexed citations
17.
Yang, Wenting, Shuang Chen, Chun-shuo Shan, et al.. (2017). Chinese herbal medicine for Alzheimer’s disease: Clinical evidence and possible mechanism of neurogenesis. Biochemical Pharmacology. 141. 143–155. 111 indexed citations
18.
Zheng, Qun, et al.. (2017). Ginsenoside Rb1 for Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms. Oxidative Medicine and Cellular Longevity. 2017(1). 6313625–6313625. 64 indexed citations
19.
Zhang, Kejian, Jiazhen Zhu, Xiaoyi Bao, et al.. (2017). Shexiang Baoxin Pills for Coronary Heart Disease in Animal Models: Preclinical Evidence and Promoting Angiogenesis Mechanism. Frontiers in Pharmacology. 8. 404–404. 38 indexed citations
20.
Zhang, Kejian, Jiazhen Zhu, Qun Zheng, et al.. (2017). Salvianolic Acid Exerts Cardioprotection through Promoting Angiogenesis in Animal Models of Acute Myocardial Infarction: Preclinical Evidence. Oxidative Medicine and Cellular Longevity. 2017(1). 8192383–8192383. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026